Royal Capital Wealth Management »

Taysha Gene Therapies shares owned by Royal Capital Wealth Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Royal Capital Wealth Management from 13F filings

Historical chart of Royal Capital Wealth Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Royal Capital Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Royal Capital Wealth Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $19k 11k 1.77

More positions owned by Royal Capital Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Mastercard Incorporated Cl A (MA)
Microsoft Corporation (MSFT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Visa Com Cl A (V)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Proshares Tr S&p 500 Dv Arist (NOBL)
McDonald's Corporation (MCD)
Amazon (AMZN)
Exxon Mobil Corporation (XOM)
Blackstone Group Inc Com Cl A (BX)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Royal Capital Wealth Management

Top funds holding Taysha Gene Therapies

RA Capital Management
VR Adviser
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Artal Group
Millennium Management
Point72 Asset Management
Citadel Advisors
Damian Sousa
Cowen And Company
Susquehanna International
T. Rowe Price Associates
Schonfeld Strategic Advisors
Quantum Private Wealth

View all funds holding Taysha Gene Therapies